Symmetry Peak Management’s VanEck Biotech ETF BBH Stock Holding History

Symmetry Peak Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,200	Closed	-$351K	–	118
2022 Q4	$351K	Buy	+2,200	New	+$348K	0.17%	68

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Symmetry Peak Management's BBH Position: Q1 2023 in Review

Symmetry Peak Management sold out of VanEck Biotech ETF (BBH) in Q1 2023, closing a stake of 2,200 shares — an estimated $351K sold.

Symmetry Peak Management first reported a position in BBH in Q4 2022 and held it in 1 quarter. The position peaked at $351K in Q4 2022. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2023.

Symmetry Peak Management reported no remaining VanEck Biotech ETF position as of Q1 2023 after selling out during the quarter.
Symmetry Peak Management sold 2,200 VanEck Biotech ETF shares in Q1 2023, an estimated $351K.
Symmetry Peak Management first reported a position in VanEck Biotech ETF in Q4 2022 and held it in 1 quarter.
Symmetry Peak Management's VanEck Biotech ETF position peaked at $351K in Q4 2022.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2023.

Based on Symmetry Peak Management's 13F filing for Q1 2023, filed 15 May 2023.